US Stock MarketDetailed Quotes
RARE Ultragenyx Pharmaceutical
- 42.550
- -0.230-0.54%
Close Jul 19 16:00 ET
3.85BMarket Cap-5352P/E (TTM)
43.480High42.090Low606.78KVolume42.910Open42.780Pre Close25.83MTurnover0.75%Turnover RatioLossP/E (Static)90.57MShares54.56052wk High27.47P/B3.44BFloat Cap31.52052wk Low--Dividend TTM80.73MShs Float179.647Historical High--Div YieldTTM3.25%Amplitude31.520Historical Low42.571Avg Price1Lot Size
About Ultragenyx Pharmaceutical Company
Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.
Company Profile
SymbolRARE
Company NameUltragenyx Pharmaceutical
Listing DateJan 31, 2014
Issue Price21.00
Founded2010
CEODr. Emil D. Kakkis, M.D.,PhD
MarketNASDAQ
Employees1276
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address60 Leveroni Court
CityNovato
ProvinceCalifornia
CountryUnited States of America
Zip Code94949
Phone1-415-483-8800
Websitehttp://www.ultragenyx.com
Company Executives
- Name
- Position
- Salary
- Dr. Emil D. Kakkis, M.D.,PhD
- Director, President, Chief Executive Officer
- 13.08M
- John Richard Pinion, II
- Chief Quality Officer and Executive Vice President, Translational Sciences
- 4.05M
- Thomas R. Kassberg
- Chief Business Officer and Executive Vice President
- --
- Karah Parschauer
- Chief Legal Officer and Executive Vice President, Corporate Affairs
- 4.04M
- Howard Horn
- Chief Financial Officer and Executive Vice President, Corporate Strategy
- 5.94M
- Dennis Karl Huang
- Chief Technical Operations Officer and Executive Vice President, Gene Therapy Operations
- --
- Dr. Eric Crombez, M.D.
- Executive Vice President and Chief Medical Officer
- --
- Theodore A. Huizenga
- Senior Vice President, Corporate Controller and Chief Accounting Officer
- --
- Erik Harris
- Chief Commercial Officer and Executive Vice President
- 4.07M
- Daniel G. Welch
- Chairman of the Board
- 499.89K
- Dr. Corazon Dating Sanders, PhD
- Independent Director
- 469.39K
- Dr. Amrit Ray, M.D.
- Independent Director
- 460.39K
- Michael A. Narachi
- Independent Director
- 482.39K
- Matthew K. Fust
- Independent Director
- 479.89K
- Dr. Deborah L. Dunsire,M.D.
- Independent Director
- 459.89K
- Dr. Shehnaaz Suliman, M.D.
- Independent Director
- 466.89K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg